zymeworks inc  product pipeline review    compare about us  contact us home research category publisher list custom research cart compare research category user guide policies contact us about us site map home  market research report  pharmaceutical  pharmaceutical companies market research report zymeworks inc  product pipeline review   published by global markets direct product code  published september   content info  pages price usd  pdf by email single user license usd  pdf by email site license usd  pdf by email global license zymeworks inc  product pipeline review   published september   content info  pages description summary global markets directs zymeworks inc  product pipeline review   provides an overview of the zymeworks incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of zymeworks incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope the report provides brief overview of zymeworks inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of zymeworks incs human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the zymeworks incs pipeline products reasons to buy evaluate zymeworks incs strategic position with total access to detailed information on its product pipeline assess the growth potential of zymeworks inc in its therapy areas of focus identify new drug targets and therapeutic classes in the zymeworks incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of zymeworks inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of zymeworks inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of zymeworks inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contents product code gmdhccdbtable of contents table of contents list of tables list of figures zymeworks inc snapshot zymeworks inc overview key information key facts zymeworks inc  research and development overview key therapeutic areas zymeworks inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  outlicensed products outlicensed productscombination treatment modalities zymeworks inc  pipeline products glance zymeworks inc  early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities zymeworks inc  drug profiles zw product description mechanism of action rd progress zw product description mechanism of action rd progress zw product description mechanism of action rd progress zw product description mechanism of action rd progress zw product description mechanism of action rd progress monoclonal antibodies for cancer and autoimmune disease product description mechanism of action rd progress monoclonal antibody conjugated for colorectal cancer product description mechanism of action rd progress monoclonal antibody conjugated for lung cancer product description mechanism of action rd progress monoclonal antibody for autoimmune disease product description mechanism of action rd progress monoclonal antibody for cancer autoimmune and inflammatory diseases product description mechanism of action rd progress monoclonal antibody for solid tumors product description mechanism of action rd progress monoclonal antibody to modulate tcell for solid tumors product description mechanism of action rd progress monoclonal antibody to target tcell receptor for colorectal cancer product description mechanism of action rd progress zymeworks inc  pipeline analysis zymeworks inc  pipeline products by target zymeworks inc  pipeline products by molecule type zymeworks inc  pipeline products by mechanism of action zymeworks inc  recent pipeline updates zymeworks inc  dormant projects zymeworks inc  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tables zymeworks inc key information zymeworks inc key facts zymeworks inc  pipeline by indication  zymeworks inc  pipeline by stage of development  zymeworks inc  monotherapy products in pipeline  zymeworks inc  outlicensed products in pipeline  zymeworks inc  outlicensed products combination treatment modalities  zymeworks inc  preclinical  zymeworks inc  discovery  zymeworks inc  pipeline by target  zymeworks inc  pipeline by molecule type  zymeworks inc  pipeline products by mechanism of action  zymeworks inc  recent pipeline updates  zymeworks inc  dormant developmental projects zymeworks inc other locations list of figures zymeworks inc  pipeline by top  indication  zymeworks inc  pipeline by stage of development  zymeworks inc  monotherapy products in pipeline  zymeworks inc  pipeline by top  target  zymeworks inc  pipeline by top  molecule type  zymeworks inc  pipeline products by top  mechanism of action  phone intl  tollfreeus  europe  asia  new for   gii now purchases any market research reports from any publishers for you with noextra cost contact us for more details faq delivery time user license payment options compare multiple reports about contact user guide policies site map  copyright  global information inc all rights reserved stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  zymeworks inc private company information  bloomberg july    am et biotechnology company overview of zymeworks inc snapshot people company overview zymeworks inc a clinicalstage biopharmaceutical company engages in the discovery development and commercialization of biotherapeutics for the treatment of cancer in canada the company’s lead product candidate include zw a novel bispecific antibody that is in phase i clinical trial for the treatment of breast gastric and ovarian cancers it is also developing zw a bispecific antihuman epidermal growth factor receptor  antibodydrug conjugate that is in preclinical development stage for the treatment of breast and ovarian cancers the company has strategic partnerships with merck sharp  dohme research ltd eli lilly and company celgene corporation and celgene alpine invest zymeworks inc a clinicalstage biopharmaceutical company engages in the discovery development and commercialization of biotherapeutics for the treatment of cancer in canada the company’s lead product candidate include zw a novel bispecific antibody that is in phase i clinical trial for the treatment of breast gastric and ovarian cancers it is also developing zw a bispecific antihuman epidermal growth factor receptor  antibodydrug conjugate that is in preclinical development stage for the treatment of breast and ovarian cancers the company has strategic partnerships with merck sharp  dohme research ltd eli lilly and company celgene corporation and celgene alpine investment co llc glaxosmithkline intellectual property development limited and daiichi sankyo co ltd zymeworks inc was founded in  and is headquartered in vancouver canada detailed description  west th avenuesuite vancouver bc vh vcanadafounded in  employees phone  fax  wwwzymeworkscom key executives for zymeworks inc dr ali tehrani phd cofounder chief executive officer president and director age  total annual compensation k mr neil klompas cpa ca chief financial officer age  total annual compensation k dr diana f hausman md chief medical officer age  total annual compensation k mr john babcook senior vice president of discovery research age  total annual compensation k dr surjit dixit phd vice president of technology age  total annual compensation k compensation as of fiscal year  zymeworks inc key developments zymeworks and daiichi sankyo announce successful achievement of a research milestone in bispecific antibody collaboration jul   zymeworks inc and daiichi sankyo company limited announced the successful achievement of a research milestone for an immunooncology bispecific antibody therapeutic candidate in their collaboration in conjunction with this achievement zymeworks is to receive a payment of one million dollars from daiichi sankyo under the terms of their existing agreement signed on september   zymeworks granted daiichi sankyo a license to zymeworks azymetric and efect platforms to develop a bispecific antibody therapeutic for which zymeworks is eligible to receive preclinical clinical and commercial milestone payments as well as up to doubledigit tiered royalties on global product sales additionally zymeworks obtained a license to certain immunooncology antibodies from daiichi sankyo with the right to research develop and commercialize multiple bispecific products globally in exchange for royalties on global product sales zymeworks inc presents safety and antitumor activity data from the ongoing phase  study of zw jun   zymeworks inc announced results from the dose escalation portion of the firstinhuman study of zw a novel azymetric™ bispecific antibody targeting two distinct domains of the her receptor zw was welltolerated at all dose levels evaluated with single agent antitumor activity in patients with advanced herexpressing cancers that had progressed after multiple lines of therapy including hertargeted agents these results provide the framework for further advancement of zw across multiple cancer indications a total of  patients were enrolled in the study including  with breast cancer  with gastric gastroesophageal junction or esophageal ge cancer and  with other herexpressing cancers all patients were heavily pretreated having received a median of  prior systemic regimens for metastatic disease which included trastuzumab breast cancer patients were also treated with tdm n pertuzumab n and lapatinib n and had a median of  prior hertargeted regimens for metastatic disease patients were treated with weekly zw at  mgkg n  mgkg n or  mgkg n in cycles of  weeks each zw was welltolerated at all dose levels with no doselimiting toxicities the majority of adverse events aes were grade  or  with no treatmentrelated serious aes and no changes in cardiac function the most common aes were diarrhea and infusion reactions reported in  patients each treatmentrelated grade  aes occurred in a single patient and included hypophosphatemia fatigue and arthralgia eight patients had antidrug antibodies ada prior to initiating treatment with zw there was no evidence of increases from baseline levels and no patients developed new ada durable singleagent antitumor activity was seen with patients having received up to  cycles of treatment at the time of data cutoff in  responseevaluable patients defined as undergoing at least one tumor restaging best overall response bor was  partial response pr  stable disease sd and  progressive disease pd the majority of patients with measurable disease had a decrease in the size of target lesions bor in  breast cancer patients was  pr  sd   months in one patient and  pd for an overall disease control rate cr pr or sd of  three of the breast cancer patients developed pd due to brain metastases but maintained systemic disease control at the time of progression bor in  responseevaluable patients with ge cancers included sd   cycles in  patient and  pd four patients remain active on study zymeworks inc to present its phase  clinical trial dose escalation data at the american society of clinical oncology annual meeting may   zymeworks inc announced that it will be presenting phase  clinical trial dose escalation data at the american society of clinical oncology asco annual meeting being held from june   in chicago illinois the presentation will include detailed safety and preliminary antitumor activity data for the dose escalation stage of zymeworks phase  clinical trial of zw zymeworks lead product candidate presenting on behalf of zymeworks will be lead investigator dr funda mericbernstam md dr mericbernstam is chair department of investigational cancer therapeutics medical director khalifa institute for personalized cancer therapy nellie b connally chair in breast cancer research and professor divisions of cancer medicine and surgury at the university of texas md anderson cancer center and the university of texas zw is zymeworks lead product candidate currently being evaluated in an adaptive phase  clinical trial in the united states based on zymeworks azymetric platform it is a bispecific antibody that can simultaneously bind two nonoverlapping epitopes known as biparatopic binding of her resulting in dual her signal blockade increased binding and removal of her protein from the cell surface and enhanced effector function these combined mechanisms of action have led to significant antitumor activity in preclinical models of breast cancer zymeworks is developing zw as a bestinclass hertargeting antibody intended as a treatment option for patients with any solid tumor that expresses her similar private companies by industry company name region  ontario inc americas  ontario inc americas ab biopharma inc americas abcelex technologies inc americas abcellera biologics inc americas recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact zymeworks inc please visit wwwzymeworkscom company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close market report zymeworks inc  product pipeline review   about us • publishers • contact us • cart login  register all industries business  finance  business  financial services  insurance  marketing consumer  food  beverages  consumer goods  food  retailing healthcare  biotechnology  healthcare  medical devices  pharmaceuticals heavy industry  construction  energy  manufacturing  materials  transportation internet  media  ebusiness  internet  media  publishing public sector  defense  education  government telecom  computing  computer technology  fixed networks  software  wireless companycountry reports  company reports  country reports  regional reports   processing zymeworks inc  product pipeline review   sep    global markets direct   pages  usd  click here to open the popup youve added the following report to your cartclose cart summary total items subtotal      report summary table of contents companies request details related global markets directs zymeworks inc  product pipeline review   provides an overview of the zymeworks incs pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of zymeworks incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasereport scopethe report provides brief overview of zymeworks inc including business description key information and facts and its locations and subsidiariesthe report reviews current pipeline of zymeworks incs human therapeutic division and enlists all their major and minor projectsthe report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestonesspecial feature on outlicensed and partnered product portfoliothe report summarizes all the dormant and discontinued pipeline projectslatest company statementlatest news and deals relating to the zymeworks incs pipeline productsreasons to get this reportevaluate zymeworks incs strategic position with total access to detailed information on its product pipelineassess the growth potential of zymeworks inc in its therapy areas of focusidentify new drug targets and therapeutic classes in the zymeworks incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areasexploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gapsdevelop strategic initiatives by understanding the focus areas of zymeworks inc and exploit collaboration and partnership opportunitiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantageplan mergers and acquisitions effectively by identifying the most promising pipeline of zymeworks incdevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeexplore the dormant and discontinued projects of zymeworks inc and identify potential opportunities in those areasavoid intellectual property rights related issues table of contentstable of contents list of tables list of figures zymeworks inc snapshot zymeworks inc overview key information key facts zymeworks inc  research and development overview key therapeutic areas zymeworks inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  outlicensed products outlicensed productscombination treatment modalities zymeworks inc  pipeline products glance zymeworks inc  early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities zymeworks inc  drug profiles zw product description mechanism of action rd progress zw product description mechanism of action rd progress zw product description mechanism of action rd progress zw product description mechanism of action rd progress zw product description mechanism of action rd progress monoclonal antibodies for cancer and autoimmune disease product description mechanism of action rd progress monoclonal antibody conjugated for colorectal cancer product description mechanism of action rd progress monoclonal antibody conjugated for lung cancer product description mechanism of action rd progress monoclonal antibody for autoimmune disease product description mechanism of action rd progress monoclonal antibody for cancer autoimmune and inflammatory diseases product description mechanism of action rd progress monoclonal antibody for solid tumors product description mechanism of action rd progress monoclonal antibody to modulate tcell for solid tumors product description mechanism of action rd progress monoclonal antibody to target tcell receptor for colorectal cancer product description mechanism of action rd progress zymeworks inc  pipeline analysis zymeworks inc  pipeline products by target zymeworks inc  pipeline products by molecule type zymeworks inc  pipeline products by mechanism of action zymeworks inc  recent pipeline updates zymeworks inc  dormant projects zymeworks inc  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tableszymeworks inc key information zymeworks inc key facts zymeworks inc  pipeline by indication  zymeworks inc  pipeline by stage of development  zymeworks inc  monotherapy products in pipeline  zymeworks inc  outlicensed products in pipeline  zymeworks inc  outlicensed products combination treatment modalities  zymeworks inc  preclinical  zymeworks inc  discovery  zymeworks inc  pipeline by target  zymeworks inc  pipeline by molecule type  zymeworks inc  pipeline products by mechanism of action  zymeworks inc  recent pipeline updates  zymeworks inc  dormant developmental projects zymeworks inc other locations list of figureszymeworks inc  pipeline by top  indication  zymeworks inc  pipeline by stage of development  zymeworks inc  monotherapy products in pipeline  zymeworks inc  pipeline by top  target  zymeworks inc  pipeline by top  molecule type  zymeworks inc  pipeline products by top  mechanism of action   companies mentioned in this reportzymeworks inc this report does not have a press release associated with it order today format pdf  usd license single user delivery by email   business day the fast market research advantage only the best all of our research is sourced from the most trusted and established global analysts and consultancies client focused from startups to multinationals we focus on providing the right research to our diverse client base shop securely our usbased customer service team and ecommerce systems adhere to the highest data security standards industryleading customer support individualized assistance from our expert staff is never more than an email or phone call away best price guarantee we are committed to providing the best research at the lowest cost we will match any published price for the same report guaranteed easy ordering once you’ve found the right report click ‘order now’ and complete the checkout process using any major credit card check or wirebank transferneed multiuser or enterprise license pricing contact us for a custom quote about the publisher global markets direct is a leading provider of global business intelligence and market analysis it publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industryspecific information publisher details privacy policy  terms of use  flashalerts copyright copy  fast market research inc stockscountryunited states index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  zyme stock price  zymeworks inc stock quote us nyse  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern a breaking elon musk details tesla model  pricing range a tesla standard model  will cost  longrange model will cost   updated wall street isn’t ready for a point tumble in the dow industrials  barrons buzz robo  facebook and twitter trading on news  a wild week in washington  updated the dark side of cruises  trump to police dont be too nice  updated the highest paid athletes in the world in one chart  updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family  updated here are  coworkers you should avoid like the plague — especially in meetings to be replaced home investing quotes stocks united states zyme overview compare quotes stock screener earnings calendar sectors nyse zyme us nyse join td ameritrade find a broker zymeworks inc watchlist createzymealert closed last updated jul    am jst delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap na shares outstanding m public float m beta  rev per employee na pe ratio na eps na yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  recent news marketwatch other dow jones zymeworks started at buy with  stock price target at canaccord genuity zymeworks started at buy with  stock price target at canaccord genuity may   at  am et by tomi kilgore no headlines available recent news other news press releases zymeworks earns m research milestone from daiichi related to io antibody zymeworks earns m research milestone from daiichi related to io antibody jul   at  am et on seeking alpha zymeworks synonymous with best in class zymeworks synonymous with best in class jul   at  pm et on seeking alpha ipo market reignites with strong quarterly performance the market for initial public offerings in the second quarter was the busiest period in two years in both proceeds and number of deals completed an ipo research firm says renaissance capital which manages two iporelated exchange traded funds said there were  ipos during the period the most since the  in the second quarter of  they raised  billion also the most since the  billion raised in the same period two years ago jun   at  pm et on investors business daily zymeworks inc closes the market zymeworks inc closes the market jun   at  pm et on cnw group stocks to watch next week stocks to watch next week jun   at  pm et on seeking alpha zymeworks sells off after flurry of sellside upgrades down  today zymeworks sells off after flurry of sellside upgrades down  today jun   at  pm et on seeking alpha premarket analyst action  healthcare premarket analyst action  healthcare may   at  am et on seeking alpha cloudera carvana complete ipos with one up one down apr   at  am et on investors business daily ipo preview zymeworks inc apr   at  am et on seeking alpha zymeworks readies ipo apr   at  am et on seeking alpha zymeworks and daiichi sankyo announce successful achievement of a research milestone in bispecific antibody collaboration zymeworks and daiichi sankyo announce successful achievement of a research milestone in bispecific antibody collaboration jul   at  am et on businesswire  bzx drug candidates developed using zymeworks’ azymetric platform nominated for latestage preclinical development by lilly drug candidates developed using zymeworks’ azymetric platform nominated for latestage preclinical development by lilly jun   at  am et on businesswire  bzx zymeworks presents safety and antitumor activity data from the ongoing phase  study of zw at the american society of clinical oncology annual meeting asco  zymeworks presents safety and antitumor activity data from the ongoing phase  study of zw at the american society of clinical oncology annual meeting asco  jun   at  am et on businesswire  bzx zymeworks announces closing of partial exercise of overallotment option for its initial public offering zymeworks announces closing of partial exercise of overallotment option for its initial public offering may   at  am et on businesswire  bzx zymeworks announces partial exercise of overallotment option for its initial public offering zymeworks announces partial exercise of overallotment option for its initial public offering may   at  am et on businesswire  bzx zymeworks to present at the  american society of clinical oncology annual meeting zymeworks to present at the  american society of clinical oncology annual meeting may   at  pm et on businesswire  bzx zymeworks reports first quarter  financial results zymeworks reports first quarter  financial results may   at  pm et on businesswire  bzx zymeworks to present at ubs global healthcare conference zymeworks to present at ubs global healthcare conference may   at  am et on businesswire  bzx zymeworks to host first quarter  financial results conference call on may   zymeworks to host first quarter  financial results conference call on may   may   at  pm et on businesswire  bzx zymeworks thanks resigning directors for their service zymeworks thanks resigning directors for their service may   at  am et on businesswire  bzx zymeworks announces closing of initial public offering zymeworks announces closing of initial public offering may   at  am et on businesswire  bzx iiroc trade resumption  zymeworks inc apr   at  am et on newsfile corp iiroc trade halt  zymeworks inc apr   at  am et on newsfile corp zymeworks announces pricing of initial public offering apr   at  pm et on businesswire  bzx zymeworks inc zymeworks inc is a clinicalstage biopharmaceutical company which discovers develops and commercializes biotherapeutics with a focus on treatment of cancer its lead product zw is a novel bispecific antibody currently being evaluated in an adaptive phase  clinical trial the company engages in preclinical and discoverystage programs in immunooncology and other therapeutic areas zymeworks was founded by anthony fejes j haig deb farris nick bedford ali tehrani and andrew s wright in  and is headquartered in vancouver canada see full profile analyst ratings sell under hold over buy number of ratings  full ratings zymeworks early but compelling data large biopharma partners and a potential june catalyst may   at  pm et on benzingacom competitors name chg  market cap omeros corp  m ohr pharmaceutical inc  m oncomed pharmaceuticals inc  m omni bio pharmaceutical inc  m competitor data provided by partner content trending tickers powered by dvax  sq  wfc  ben  wy  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience zymeworks inc  product pipeline review   about us solutions resources ebookswhite papers slideshares videos blog contact us register log in my account logout browse research my cart menu   close   x browse about us solutions resources contact us log out register log in life sciences»pharmaceuticals»pharmaceuticals company reports zymeworks inc  product pipeline review   lowest prices guaranteed length publisher published date sku from   pages global markets direct september  gmd lowest prices guaranteed price from  length  pages publisher global markets direct published date september  sku gmd table of contents close window table of contents zymeworks inc  product pipeline review   printer format global markets direct zymeworks inc snapshot zymeworks inc overview key information key facts zymeworks inc  research and development overview key therapeutic areas zymeworks inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  outlicensed products outlicensed productscombination treatment modalities zymeworks inc  pipeline products glance zymeworks inc  early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities zymeworks inc  drug profiles zw product description mechanism of action rd progress zw product description mechanism of action rd progress zw product description mechanism of action rd progress zw product description mechanism of action rd progress zw product description mechanism of action rd progress monoclonal antibodies for cancer and autoimmune disease product description mechanism of action rd progress monoclonal antibody conjugated for colorectal cancer product description mechanism of action rd progress monoclonal antibody conjugated for lung cancer product description mechanism of action rd progress monoclonal antibody for autoimmune disease product description mechanism of action rd progress monoclonal antibody for cancer autoimmune and inflammatory diseases product description mechanism of action rd progress monoclonal antibody for solid tumors product description mechanism of action rd progress monoclonal antibody to modulate tcell for solid tumors product description mechanism of action rd progress monoclonal antibody to target tcell receptor for colorectal cancer product description mechanism of action rd progress zymeworks inc  pipeline analysis zymeworks inc  pipeline products by target zymeworks inc  pipeline products by molecule type zymeworks inc  pipeline products by mechanism of action zymeworks inc  recent pipeline updates zymeworks inc  dormant projects zymeworks inc  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tableszymeworks inc key information zymeworks inc key facts zymeworks inc  pipeline by indication  zymeworks inc  pipeline by stage of development  zymeworks inc  monotherapy products in pipeline  zymeworks inc  outlicensed products in pipeline  zymeworks inc  outlicensed products combination treatment modalities  zymeworks inc  preclinical  zymeworks inc  discovery  zymeworks inc  pipeline by target  zymeworks inc  pipeline by molecule type  zymeworks inc  pipeline products by mechanism of action  zymeworks inc  recent pipeline updates  zymeworks inc  dormant developmental projects zymeworks inc other locations list of figureszymeworks inc  pipeline by top  indication  zymeworks inc  pipeline by stage of development  zymeworks inc  monotherapy products in pipeline  zymeworks inc  pipeline by top  target  zymeworks inc  pipeline by top  molecule type  zymeworks inc  pipeline products by top  mechanism of action  description close window description zymeworks inc  product pipeline review   printer format global markets direct zymeworks inc  product pipeline review  summaryglobal markets direct’s ‘zymeworks inc  product pipeline review  ’ provides an overview of the zymeworks inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of zymeworks inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescopethe report provides brief overview of zymeworks inc including business description key information and facts and its locations and subsidiariesthe report reviews current pipeline of zymeworks inc’s human therapeutic division and enlists all their major and minor projectsthe report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones special feature on outlicensed and partnered product portfoliothe report summarizes all the dormant and discontinued pipeline projectslatest company statement latest news and deals relating to the zymeworks inc’s pipeline productsreasons to buyevaluate zymeworks inc’s strategic position with total access to detailed information on its product pipelineassess the growth potential of zymeworks inc in its therapy areas of focusidentify new drug targets and therapeutic classes in the zymeworks inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areasexploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gapsdevelop strategic initiatives by understanding the focus areas of zymeworks inc and exploit collaboration and partnership opportunitiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantageplan mergers and acquisitions effectively by identifying the most promising pipeline of zymeworks incdevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeexplore the dormant and discontinued projects of zymeworks inc and identify potential opportunities in those areasavoid intellectual property rights related issues search inside this report close window search inside this report online download  purchase site license  purchase global site license  purchase   research assistance us  intl  download our ebook how to succeed using market research learn how to effectively navigate the market research process to help guide your organization on the journey to success download ebook share this report other tasks printer format order by fax currency converter zyme stock price  zymeworks inc stock quote us nyse  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern a breaking elon musk details tesla model  pricing range a tesla standard model  will cost  longrange model will cost   updated wall street isn’t ready for a point tumble in the dow industrials  barrons buzz robo  facebook and twitter trading on news  a wild week in washington  updated the dark side of cruises  trump to police dont be too nice  updated the highest paid athletes in the world in one chart  updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family  updated here are  coworkers you should avoid like the plague — especially in meetings to be replaced home investing quotes stocks united states zyme overview compare quotes stock screener earnings calendar sectors nyse zyme us nyse join td ameritrade find a broker zymeworks inc watchlist createzymealert closed last updated jul    am jst delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap na shares outstanding m public float m beta  rev per employee na pe ratio na eps na yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  recent news marketwatch other dow jones zymeworks started at buy with  stock price target at canaccord genuity zymeworks started at buy with  stock price target at canaccord genuity may   at  am et by tomi kilgore no headlines available recent news other news press releases zymeworks earns m research milestone from daiichi related to io antibody zymeworks earns m research milestone from daiichi related to io antibody jul   at  am et on seeking alpha zymeworks synonymous with best in class zymeworks synonymous with best in class jul   at  pm et on seeking alpha ipo market reignites with strong quarterly performance the market for initial public offerings in the second quarter was the busiest period in two years in both proceeds and number of deals completed an ipo research firm says renaissance capital which manages two iporelated exchange traded funds said there were  ipos during the period the most since the  in the second quarter of  they raised  billion also the most since the  billion raised in the same period two years ago jun   at  pm et on investors business daily zymeworks inc closes the market zymeworks inc closes the market jun   at  pm et on cnw group stocks to watch next week stocks to watch next week jun   at  pm et on seeking alpha zymeworks sells off after flurry of sellside upgrades down  today zymeworks sells off after flurry of sellside upgrades down  today jun   at  pm et on seeking alpha premarket analyst action  healthcare premarket analyst action  healthcare may   at  am et on seeking alpha cloudera carvana complete ipos with one up one down apr   at  am et on investors business daily ipo preview zymeworks inc apr   at  am et on seeking alpha zymeworks readies ipo apr   at  am et on seeking alpha zymeworks and daiichi sankyo announce successful achievement of a research milestone in bispecific antibody collaboration zymeworks and daiichi sankyo announce successful achievement of a research milestone in bispecific antibody collaboration jul   at  am et on businesswire  bzx drug candidates developed using zymeworks’ azymetric platform nominated for latestage preclinical development by lilly drug candidates developed using zymeworks’ azymetric platform nominated for latestage preclinical development by lilly jun   at  am et on businesswire  bzx zymeworks presents safety and antitumor activity data from the ongoing phase  study of zw at the american society of clinical oncology annual meeting asco  zymeworks presents safety and antitumor activity data from the ongoing phase  study of zw at the american society of clinical oncology annual meeting asco  jun   at  am et on businesswire  bzx zymeworks announces closing of partial exercise of overallotment option for its initial public offering zymeworks announces closing of partial exercise of overallotment option for its initial public offering may   at  am et on businesswire  bzx zymeworks announces partial exercise of overallotment option for its initial public offering zymeworks announces partial exercise of overallotment option for its initial public offering may   at  am et on businesswire  bzx zymeworks to present at the  american society of clinical oncology annual meeting zymeworks to present at the  american society of clinical oncology annual meeting may   at  pm et on businesswire  bzx zymeworks reports first quarter  financial results zymeworks reports first quarter  financial results may   at  pm et on businesswire  bzx zymeworks to present at ubs global healthcare conference zymeworks to present at ubs global healthcare conference may   at  am et on businesswire  bzx zymeworks to host first quarter  financial results conference call on may   zymeworks to host first quarter  financial results conference call on may   may   at  pm et on businesswire  bzx zymeworks thanks resigning directors for their service zymeworks thanks resigning directors for their service may   at  am et on businesswire  bzx zymeworks announces closing of initial public offering zymeworks announces closing of initial public offering may   at  am et on businesswire  bzx iiroc trade resumption  zymeworks inc apr   at  am et on newsfile corp iiroc trade halt  zymeworks inc apr   at  am et on newsfile corp zymeworks announces pricing of initial public offering apr   at  pm et on businesswire  bzx zymeworks inc zymeworks inc is a clinicalstage biopharmaceutical company which discovers develops and commercializes biotherapeutics with a focus on treatment of cancer its lead product zw is a novel bispecific antibody currently being evaluated in an adaptive phase  clinical trial the company engages in preclinical and discoverystage programs in immunooncology and other therapeutic areas zymeworks was founded by anthony fejes j haig deb farris nick bedford ali tehrani and andrew s wright in  and is headquartered in vancouver canada see full profile analyst ratings sell under hold over buy number of ratings  full ratings zymeworks early but compelling data large biopharma partners and a potential june catalyst may   at  pm et on benzingacom competitors name chg  market cap omeros corp  m ohr pharmaceutical inc  m oncomed pharmaceuticals inc  m omni bio pharmaceutical inc  m competitor data provided by partner content trending tickers powered by dvax  sq  wfc  ben  wy  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience zymeworks inc  product pipeline review   infomarketreportscentercom  us x login sign up facebook twitter linkedin google  mrc blog youtube zymeworks inc  product pipeline review   home  pharmaceuticals  global markets direct  zymeworks inc  product pipeline review   report details zymeworks inc  product pipeline review   sku gmdsep category pharmaceuticals publisher global markets direct pages  published sep skugmdsep categorypharmaceuticals publisherglobal markets direct pages published onsep request discount pay by wireinvoice description table of content list of figures request sample description zymeworks inc  product pipeline review   summary global markets directs zymeworks inc  product pipeline review   provides an overview of the zymeworks incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of zymeworks incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope  the report provides brief overview of zymeworks inc including business description key information and facts and its locations and subsidiaries  the report reviews current pipeline of zymeworks incs human therapeutic division and enlists all their major and minor projects  the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones  special feature on outlicensed and partnered product portfolio  the report summarizes all the dormant and discontinued pipeline projects  latest company statement  latest news and deals relating to the zymeworks incs pipeline products reasons to buy  evaluate zymeworks incs strategic position with total access to detailed information on its product pipeline  assess the growth potential of zymeworks inc in its therapy areas of focus  identify new drug targets and therapeutic classes in the zymeworks incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas  exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps  develop strategic initiatives by understanding the focus areas of zymeworks inc and exploit collaboration and partnership opportunities  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  plan mergers and acquisitions effectively by identifying the most promising pipeline of zymeworks inc  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope  explore the dormant and discontinued projects of zymeworks inc and identify potential opportunities in those areas  avoid intellectual property rights related issues newspress release precision medicine how the life science industry can improve outcomes through to achieve successful precision medicine at scale and to be able to offer it as an everyday treatment option researchers in drug rd need to better understand and manage the reams of unstructured datread more regenerative medicine market to hit  billion by  the current regenerative medicine market is worth  billion globally and will hit over  billion by  as impact of trump administrationread more  benefits of microneedlingmicroneedling hundreds of tiny pin pricks going into your skin might sound weird but it could just be the best thing that ever happened to your faceread more table of content table of contents table of contents  list of tables  list of figures  zymeworks inc snapshot  zymeworks inc overview  key information  key facts  zymeworks inc  research and development overview  key therapeutic areas  zymeworks inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  pipeline products  outlicensed products  outlicensed productscombination treatment modalities  zymeworks inc  pipeline products glance  zymeworks inc  early stage pipeline products  preclinical productscombination treatment modalities  discovery productscombination treatment modalities  zymeworks inc  drug profiles  zw  product description  mechanism of action  rd progress  zw  product description  mechanism of action  rd progress  zw  product description  mechanism of action  rd progress  zw  product description  mechanism of action  rd progress  zw  product description  mechanism of action  rd progress  monoclonal antibodies for cancer and autoimmune disease  product description  mechanism of action  rd progress  monoclonal antibody conjugated for colorectal cancer  product description  mechanism of action  rd progress  monoclonal antibody conjugated for lung cancer  product description  mechanism of action  rd progress  monoclonal antibody for autoimmune disease  product description  mechanism of action  rd progress  monoclonal antibody for cancer autoimmune and inflammatory diseases  product description  mechanism of action  rd progress  monoclonal antibody for solid tumors  product description  mechanism of action  rd progress  monoclonal antibody to modulate tcell for solid tumors  product description  mechanism of action  rd progress  monoclonal antibody to target tcell receptor for colorectal cancer  product description  mechanism of action  rd progress  zymeworks inc  pipeline analysis  zymeworks inc  pipeline products by target  zymeworks inc  pipeline products by molecule type  zymeworks inc  pipeline products by mechanism of action  zymeworks inc  recent pipeline updates  zymeworks inc  dormant projects  zymeworks inc  locations and subsidiaries  head office  other locations  subsidiaries  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of figures list of tables zymeworks inc key information  zymeworks inc key facts  zymeworks inc  pipeline by indication   zymeworks inc  pipeline by stage of development   zymeworks inc  monotherapy products in pipeline   zymeworks inc  outlicensed products in pipeline   zymeworks inc  outlicensed products combination treatment modalities   zymeworks inc  preclinical   zymeworks inc  discovery   zymeworks inc  pipeline by target   zymeworks inc  pipeline by molecule type   zymeworks inc  pipeline products by mechanism of action   zymeworks inc  recent pipeline updates   zymeworks inc  dormant developmental projects  zymeworks inc other locations  list of figures zymeworks inc  pipeline by top  indication   zymeworks inc  pipeline by stage of development   zymeworks inc  monotherapy products in pipeline   zymeworks inc  pipeline by top  target   zymeworks inc  pipeline by top  molecule type   zymeworks inc  pipeline products by top  mechanism of action   please select license type single user electronic pdf   site user electronic pdf   enterprise wide electronic pdf   add to cart buy now related reports global fiberglass electronic products market professional survey report  global fiberglass electrical products market professional survey report  global biochip products market professional survey report  global aluminum flatrolled product market professional survey report  global thermal spray products sales market report  request sample mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send request discount mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send pay by wireinvoice mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  single user electronic pdf site user electronic pdf enterprise wide electronic pdf cd rom hard copy send request quote mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send market reports center  copyright  all rights reserved overview  zymeworks skip to main content companyoverview management team board of directors news publications careersoverview current opportunities benefits core values  culture contact our approachoverview zymecad™ engine protein engineering our platformsoverview azymetric™ albucore™ efect™ zymelink™  cytotoxins our pipelineoverview zw zw investorsoverview stock information events and presentations financial documents news releases governance investor information partnersoverview corporate partners academic partners government partners our approachoverview zymecad™ engine protein engineering our platformsoverview azymetric™ albucore™ efect™ zymelink™  cytotoxins our pipelineoverview zw zw investorsoverview stock information events and presentations financial documents news releases governance investor information partnersoverview corporate partners academic partners government partners our approachoverview zymecad™ engine protein engineering our platformsoverview azymetric™ albucore™ efect™ zymelink™  cytotoxins our pipelineoverview zw zw investorsoverview stock information events and presentations financial documents news releases governance investor information partnersoverview corporate partners academic partners government partners companyoverview management team board of directors news publications careersoverview current opportunities benefits core values  culture contact our pipeline overview we currently have one whollyowned product candidate in clinical development and several whollyowned product candidates in preclinical development that leverage our multiple therapeutic platforms to address areas of significant unmet medical need    partnering explore partnering opportunities with zymeworks related links view more on zw view more on zw contact us ion brand design zymeworks inc  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports zymeworks inc  product pipeline review   zymeworks inc  product pipeline review   wgr  may  global  pages global markets direct description table of content sample report enquiry before buy related reports zymeworks inc  product pipeline review  summaryglobal markets direct’s ‘zymeworks inc  product pipeline review  ’ provides an overview of the zymeworks inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of zymeworks inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescope the report provides brief overview of zymeworks inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of zymeworks inc’s human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement  latest news and deals relating to the zymeworks inc’s pipeline productsreasons to buy evaluate zymeworks inc’s strategic position with total access to detailed information on its product pipeline assess the growth potential of zymeworks inc in its therapy areas of focus identify new drug targets and therapeutic classes in the zymeworks inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of zymeworks inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of zymeworks inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of zymeworks inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contentstable of contents list of tables list of figures zymeworks inc snapshot zymeworks inc overview key information key facts zymeworks inc  research and development overview key therapeutic areas zymeworks inc  pipeline review pipeline products by stage of development pipeline products  monotherapy zymeworks inc  pipeline products glance zymeworks inc  early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities zymeworks inc  unknown stage pipeline products unknown productscombination treatment modalities zymeworks inc  drug profiles conjugated monoclonal antibody for breast cancer product description mechanism of action rd progress monoclonal antibody drug conjugate for cancer product description mechanism of action rd progress monoclonal antibody for bcell lymphomas and leukemias product description mechanism of action rd progress monoclonal antibody for cancer product description mechanism of action rd progress monovalent antibody for cancer product description mechanism of action rd progress monoclonal antibody for autoimmune disease product description mechanism of action rd progress monoclonal antibody for cancer autoimmune and inflammatory diseases product description mechanism of action rd progress program product description mechanism of action rd progress monoclonal antibodies for cancer product description mechanism of action rd progress zymeworks inc  pipeline analysis zymeworks inc  pipeline products by target zymeworks inc  pipeline products by molecule type zymeworks inc  pipeline products by mechanism of action zymeworks inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tableszymeworks inc key information zymeworks inc key facts zymeworks inc  pipeline by indication  zymeworks inc  pipeline by stage of development  zymeworks inc  monotherapy products in pipeline  zymeworks inc  preclinical  zymeworks inc  discovery  zymeworks inc  unknown  zymeworks inc  pipeline by target  zymeworks inc  pipeline by molecule type  zymeworks inc  pipeline products by mechanism of action  list of figureszymeworks inc  pipeline by top  indication  zymeworks inc  pipeline by stage of development  zymeworks inc  monotherapy products in pipeline  zymeworks inc  pipeline by top  target  zymeworks inc  pipeline by top  molecule type  zymeworks inc  pipeline products by top  mechanism of action   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send pharmaceuticals market research reports  pharmaceuticals industry analysis  marketresearchcom about us solutions resources ebookswhite papers slideshares videos blog contact us register log in my account logout browse research my cart menu   close   x browse about us solutions resources contact us log out register log in market research » life sciences pharmaceuticals market research reports  industry analysis the pharmaceutical industry is directly impacted by the research conducted with prescription drugs vaccines and otc drugs being manufactured based on findings from the study of life sciences clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat the market research available can provide investors and analysts credible information on the direction of pharmaceuticals anesthesia drug delivery pricing regulations and policy being developed to ensure that knowledgeable and informed decisions are made regarding industry direction show more show less filter your search filter your search anesthesia  antibiotic  biopharmaceuticals  biopharmacology  clinical nutrition  clinical trial  country overviews  dietary supplements  diseases  conditions  drug delivery  drug discovery  general pharmaceuticals  generics drugs  manufacturing packaging  detailing  overthecounter drugs  pharmaceuticals company reports  pharmacy  distribution  prescription drugs  pricing  regulation  policy  research  development  technology  therapeutic area  vaccines  global  europe  asia  north america  south america  africa  oceania  middle east  caribbean  central america  research assistance us  intl  join alert me now receive biweekly email alerts on new research sign up find out more on our blog pharmaceuticals industry research  market reports sort by title az title za price lowtohigh price hightolow date date older first refine your search close window refine your search title publisher keyword priceusd to date any date last month last  months last  months last year last  years region all regions africa    algeria    angola    benin    botswana    burkina faso    burundi    cameroon    cape verde    central african republic    chad    comoros    the congo    the congo    cote divoire    djibouti    egypt    equatorial guinea    eritrea    ethiopia    gabon    the gambia    ghana    guinea    guineabissau    kenya    lesotho    liberia    libya    madagascar    malawi    mali    mauritania    mauritius    mayotte    morocco    mozambique    namibia    niger    nigeria    reunion    rwanda    sao tome and principe    senegal    seychelles    sierra leone    somalia    south africa    south sudan    sudan    swaziland    tanzania    togo    tunisia    uganda    western sahara    zambia    zimbabwe asia    afghanistan    armenia    azerbaijan    bangladesh    bhutan    brunei    cambodia    china    cocos keeling islands    east timor    georgia    hong kong    india    indonesia    japan    kazakhstan    kyrgyzstan    laos    macau    malaysia    maldives    mongolia    myanmar    nepal    north korea    pakistan    papua new guinea    philippines    russia    singapore    south korea    sri lanka    taiwan    tajikistan    thailand    turkey    turkmenistan    uzbekistan    vietnam caribbean    anguilla    antigua and barbuda    aruba    the bahamas    barbados    british virgin islands    cayman islands    cuba    curacao    dominica    dominican republic    grenada    guadeloupe    haiti    jamaica    martinique    montserrat    netherlands antilles    puerto rico    saint kitts and nevis    saint lucia    saint vincent and the grenadines    sint maarten saint maarten    trinidad and tobago    turks and caicos islands    virgin islands central america    belize    costa rica    el salvador    guatemala    honduras    nicaragua    panama europe    albania    andorra    austria    belarus    belgium    bosnia and herzegovina    bulgaria    croatia    czech republic    denmark    estonia    faroe islands    finland    france    germany    gibraltar    greece    guernsey    hungary    iceland    ireland    isle of man    italy    jersey    kosovo    latvia    liechtenstein    lithuania    luxembourg    macedonia    malta    moldova    monaco    netherlands    norway    poland    portugal    romania    san marino    scotland    serbia and montenegro    slovakia    slovenia    spain    sweden    switzerland    ukraine    united kingdom global middle east    bahrain    cyprus    gaza strip    iran    iraq    israel    jordan    kuwait    lebanon    oman    palestinian territories    qatar    saudi arabia    syria    united arab emirates    yemen north america    bermuda    canada    greenland    mexico    united states oceania    american samoa    australia    cook islands    fiji    french polynesia    guam    kiribati    marshall islands    micronesia federated states of    nauru    new caledonia    new zealand    niue    norfolk island    northern mariana islands    palau    samoa    solomon islands    tonga    tuvalu    vanuatu south america    argentina    bolivia    brazil    chile    colombia    ecuador    falkland islands    french guiana    guyana    paraguay    peru    suriname    uruguay    venezuela search global cancer diagnostics market overview  test volume and sales forecasts by country laboratory universe jul    usd  etiology of major types of cancer estimates of the number of laboratories performing cancer tests as well as tenyear test volume and sales forecasts by country contains  pages and  tables please note the  read more europe hepatitis markers testing market  supplier shares and sales segment forecasts for  immunodiagnostic and nat procedures  hospitals blood banks public health labs commercial labs physician offices jul    usd  analysis of the hepatitis diagnostics market in europe france germany italy spain uk current scientific views on the hepatitis definition epidemiology and etiology are reviewed the report provides the fiveyear test volume and sales forecasts  read more tumor markers testing instrumentation review cancer diagnostic analyzers and strategic profiles of leading suppliers jul    usd  testing the report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products including their sales product portfolios distribution tactics technological knowhow new products in rampd collaborative arrangements and business strategies contains  read more cancer diagnostic instrumentation review tumor marker testing analyzers and strategic profiles of leading suppliers jul    usd  testing the report also presents strategic assessments of current and emerging suppliers of tumor marker diagnostic products including their sales product portfolios distribution tactics technological knowhow new products in rampd collaborative arrangements and business strategies  read more global hepatitis markers testing market  supplier shares and sales segment forecasts for  immunodiagnostic and nat procedures  hospitals blood banks public health labs commercial labs physician offices jul    usd  analysis of the hepatitis diagnostics market in the us europe france germany italy spain uk and japan current scientific views on the hepatitis definition epidemiology and etiology are reviewed the report provides the year test  read more intercellular adhesion molecule  major group rhinovirus receptor or cd or icam  pipeline review h  jul    usd   icam is a protein encoded by the icam gene it acts as a receptor for major receptor group rhinovirus ab capsid proteins and coxsackievirus a capsid proteins icam promotes the assembly of endothelial apical  read more mylan performance capabilities goals and strategies in the global pharmaceutical market jul    usd  implementation of effective marketing and rd programs in the dynamic and fragmented pharmaceutical market besieged by intense competition and rapid change of technological innovations the ability to anticipate new product introductions and marketing strategies is  read more valeant pharmaceuticals performance capabilities goals and strategies in the global pharmaceutical market jul    usd  development and implementation of effective marketing and rd programs in the dynamic and fragmented pharmaceutical market besieged by intense competition and rapid change of technological innovations the ability to anticipate new product introductions and marketing  read more merck performance capabilities goals and strategies in the global pharmaceutical market jul    usd  implementation of effective marketing and rd programs in the dynamic and fragmented pharmaceutical market besieged by intense competition and rapid change of technological innovations the ability to anticipate new product introductions and marketing strategies is  read more chemotherapy induced neutropenia  pipeline review h  jul    usd  neutropenia toxicology pipeline landscape chemotherapyinduced neutropenia is a very common side effect of cancer treatment symptoms include severe fatigue weakness anxiety lack of energy shortness of breath headaches pale appearance rapid heart rate or palpitations  read more perrigo performance capabilities goals and strategies in the global pharmaceutical market jul    usd  implementation of effective marketing and rd programs in the dynamic and fragmented pharmaceutical market besieged by intense competition and rapid change of technological innovations the ability to anticipate new product introductions and marketing strategies is  read more pfizer performance capabilities goals and strategies in the global pharmaceutical market jul    usd  implementation of effective marketing and rd programs in the dynamic and fragmented pharmaceutical market besieged by intense competition and rapid change of technological innovations the ability to anticipate new product introductions and marketing strategies is  read more coronary artery disease cad ischemic heart disease  pipeline review h  jul    usd   provides an overview of the coronary artery disease cad ischemic heart disease cardiovascular pipeline landscape coronary artery disease cad is the most common type of heart disease cad happens when the arteries that supply  read more hypotension  pipeline review h  jul    usd  pressure or hypotension occurs when blood pressure during and after each heartbeat is much lower than usual this means the heart brain and other parts of the body do not get enough blood symptoms include  read more cluster headache syndrome  pipeline review h  jul    usd  syndrome central nervous system pipeline landscape cluster headache is pain that occurs along one side of the head it is frequently occurs around behind or above the eye symptoms include burning sharp steady pain red  read more complex regional pain syndrome  pipeline review h  jul    usd  complex regional pain syndrome central nervous system pipeline landscape complex regional pain syndrome crps is a chronic pain condition that most often affects one limb usually after an injury crps is divided into two types  read more pressure ulcers  pipeline review h  jul    usd  landscape pressure ulcers are an injury that breaks down the skin and underlying tissue the parts of the body most at risk of developing pressure ulcers are those that are not covered by a large  read more astrazeneca performance capabilities goals and strategies in the global pharmaceutical market jul    usd  implementation of effective marketing and rd programs in the dynamic and fragmented pharmaceutical market besieged by intense competition and rapid change of technological innovations the ability to anticipate new product introductions and marketing strategies is  read more liquid handling system market by type electronic automated manual product pipette consumables workstation microplate dispensers burette application drug discovery genomics clinical diagnostics proteomics  end user  forecast to  jul    usd  systems market is expected to reach usd  billion by  at a cagr of  rapidly developing global biotechnology and pharmaceutical industries rising requirement for highthroughput screening hts increasing emphasis on data precision and  read more bayer performance capabilities goals and strategies in the global pharmaceutical market jul    usd  implementation of effective marketing and rd programs in the dynamic and fragmented pharmaceutical market besieged by intense competition and rapid change of technological innovations the ability to anticipate new product introductions and marketing strategies is  read more tumor necrosis factor receptor superfamily member  glucocorticoid induced tumor necrosis factor receptor or activation inducible tnfr family receptor or glucocorticoid induced tnfr related protein or cd or tnfrsf  pipeline review h  jul    usd  summary tumor necrosis factor receptor superfamily member  glucocorticoid induced tumor necrosis factor receptor or activation inducible tnfr family receptor or glucocorticoid induced tnfr related protein or cd or tnfrsf pipeline target constitutes close to  read more metabotropic glutamate receptor  gprcd or mglur or grm  pipeline review h  jul    usd  approximately  molecules are developed by companies and remaining by the universitiesinstitutes the latest report metabotropic glutamate receptor   pipeline review h  outlays comprehensive information on the metabotropic glutamate receptor  gprcd or  read more macrophage stimulating protein receptor cdw or protein tyrosine kinase  or p ron or cd or mstr or ec   pipeline review h  jul    usd  kinase  or p ron or cd or mstr or ec  pipeline target constitutes close to  molecules out of which approximately  molecules are developed by companies the latest report macrophage stimulating protein  read more g protein coupled bile acid receptor  g protein coupled receptor gpcr or membrane type receptor for bile acids or hbg or gpr or gpbar  pipeline review h  jul    usd  recently published report g protein coupled bile acid receptor   pipeline review h  g protein coupled bile acid receptor  g protein coupled receptor gpcr or membrane type receptor for bile acids or  read more integrin beta  gut homing receptor beta subunit or itgb  pipeline review h  jul    usd  of which approximately  molecules are developed by companies the latest report integrin beta   pipeline review h  outlays comprehensive information on the integrin beta  gut homing receptor beta subunit or itgb  read more  prev           next  start new browse consumer goods food  beverage heavy industry life sciences marketing  market research public sector service industries technology  media company reports reports by country view all market areas view all publishers